Live
- Additional Collector Conducts Surprise Visit to Boys' Hostel in Wanaparthy
- Punjab hikes maximum state-agreed price for sugarcane, highest in country
- Centre okays PAN 2.0 project worth Rs 1,435 crore to transform taxpayer registration
- Punjab minister opens development projects of Rs 120 crore in Ludhiana
- Cabinet approves Atal Innovation Mission 2.0 with Rs 2,750 crore outlay
- Centre okays Rs 3,689cr investment for 2 hydro electric projects in Arunachal
- IPL 2025 Auction: 13-year-old Vaibhav Suryavanshi becomes youngest player to be signed in tournament's history
- About 62 lakh foreign tourists arrived in India in 8 months this year: Govt
- IPL 2025 Auction: Gujarat bag Sherfane Rutherford for Rs 2.60 cr; Kolkata grab Manish Pandey for Rs 75 lakh
- Assam CM meets Governor, cabinet expansion on the cards
Move over Ebola, Zika humans may soon be infected by SARS like virus
University of North Carolina at Chapel Hill researchers have found that the newly identified virus, known as WIV1-CoV, could bind to the same receptors as SARS-CoV that infected thousands in 2002.They also showed that the virus readily and efficiently replicated in cultured human airway tissues, suggesting an ability to jump directly to humans.
Washington, D.C: According to a new study, a SARS-like virus found in Chinese horseshoe bats may be poised to infect humans.
University of North Carolina at Chapel Hill researchers have found that the newly identified virus, known as WIV1-CoV, could bind to the same receptors as SARS-CoV that infected thousands in 2002.They also showed that the virus readily and efficiently replicated in cultured human airway tissues, suggesting an ability to jump directly to humans.
The research, led by Ralph Baric, Ph.D., professor of epidemiology at UNC's Gillings School of Global Public Health, comes on the heels of two recent high-profile outbreaks, Ebola and Zika for which there are no vaccines. The two outbreaks combined claimed thousands of lives and cost billions in foregone economic growth.
Researcher Vineet Menachery said that the capacity of this group of viruses to jump into humans is greater than we originally thought, adding that while other adaptations may be required to produce an epidemic, several viral strains circulating in bat populations have already overcome the barrier of replication in human cells and suggest reemergence as a distinct possibility.
He further said that this virus may never jump to humans, but if it does, WIV1-CoV has the potential to seed a new outbreak with significant consequences for both public health and the global economy.
The research team also found that antibodies developed to treat SARS were effective in both human and animal tissue samples against WIV1-CoV, providing a potent treatment option if there were an outbreak.
However, the limitation to treat with antibodies is the same as with ZMapp, the antibody approach used for Ebola: producing it at a large enough scale to treat many people.
Also, in terms of prevention, existing vaccines against SARS would not provide protection for this new virus due to slight differences in the viral sequence.
The study is published in the journal of Proceedings of the National Academy of Sciences.
